ArticleLaboratory investigation; a journal of technical methods and pathology2017

Targeting melanoma with front-line therapy does not abrogate Nodal-expressing tumor cells.

Mary Jc Hendrix et al.PubMed ↗Publisher ↗

No numbers read from the abstract.